Emotiv

Emotiv operates at the intersection of research-grade EEG, consumer wearables, developer infrastructure, and applied brain-computer interfaces. Its portfolio ranges from the five-channel Insight headset and 14-channel EPOC X to 32-channel FLEX systems, MN8 EEG headphones, and MW20 EEG earbuds. That breadth gives Emotiv a wider hardware-to-software surface than consumer wellness products such as Oura, while its Cortex APIs, SDKs, EmotivPRO, and Emotiv Studio support researchers and developers building applications rather than only consuming biometric scores. It also competes for attention with specialized BCI and EEG companies such as Neurable and NextSense, which have emphasized brain-sensing audio products and smart earbuds. Emotiv's differentiators are its long operating history since 2011, a reported community spanning more than 100 countries, deployment across research and enterprise contexts, and an integrated platform that includes cloud tools and AI-oriented products such as Dcode.AI and Axon.

Emotiv's trajectory shows a transition from an early-stage EEG hardware company into a broader neurotechnology platform. Founded in 2011, it raised a recorded $120,000 pre-seed round on Jul 6, 2015 with Disney Accelerator and Techstars among the investors. Its current portfolio spans low-channel consumer devices, research headsets, 32-channel systems, EEG headphones, software, APIs, SDKs, and brain-data infrastructure, suggesting product expansion beyond a single hardware product. The Apr 10, 2025 lead investment in MYndspan and the Jul 4, 2025 collaboration with X-trodes point toward ecosystem development and home-monitoring applications. The Aug 28, 2025 portable-headset launch indicates continued hardware iteration aimed at healthcare and gaming. Hiring for a Hardware Electrical Engineer in Vietnam provides an additional signal of ongoing engineering investment, although the record does not quantify headcount growth. Emotiv's reported reach across 156 countries, more than 4,000 organizations, and over 23,000 scientific publications and citations indicates substantial historical adoption, but these figures are not paired with current revenue or funding disclosures.